Wire Stories

Asia Pacific Renewable Energy Policy Handbook 2022: Comprehensive Information on Major Policies Across 17 Countries – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Renewable Energy Policy Handbook 2022 Update" report has been added to…

CloudMile: Supercharging Malaysia’s Digital Economy on Three Fronts

AI and cloud tech leader CloudMile is empowering local organizations, leveraging Google infrastructure and nurturing…

CloudMile: Supercharging Malaysia’s Digital Economy on Three Fronts

AI and cloud tech leader CloudMile is empowering local organizations, leveraging Google infrastructure and nurturing…

CloudMile: Supercharging Malaysia’s Digital Economy on Three Fronts

AI and cloud tech leader CloudMile is empowering local organizations, leveraging Google infrastructure and nurturing…

Genius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%

SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a leading…

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease…

Genius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%

SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a leading…

Genius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%

SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a leading…

3D Emphasizes the Need for Substantial Board Change at Fuji Soft

Believes Fuji Soft’s Recent Commitments to Address the Company’s Issues Are a Direct Response to…

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease…